Osteoporosis in Men: An Endocrine Society Clinical Practice Guideline
Open accessThe DOI matches its Crossref record; 214 of the 216 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The aim was to formulate practice guidelines for management of osteoporosis in men. EVIDENCE: We used the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system to describe the strength of recommendations and evidence quality. CONSENSUS PROCESS: Consensus was guided by systematic evidence reviews, one in-person meeting, and multiple conference calls and e-mails. Task Force drafts were reviewed successively by The Endocrine Society's Clinical Guidelines Subcommittee and Clinical Affairs Core Committee; representatives of ASBMR, ECTS, ESE, ISCD; and members at large. At each stage, the Task Force received written comments and incorporated needed changes. The reviewed document was approved by The Endocrine Society Council before submission for peer review. CONCLUSIONS: Osteoporosis in men causes significant morbidity and mortality. We recommend testing higher risk men [aged ≥70 and men aged 50-69 who have risk factors (e.g. low body weight, prior fracture as an adult, smoking, etc.)] using central dual-energy x-ray absorptiometry. Laboratory testing should be done to detect contributing causes. Adequate calcium and vitamin D and weight-bearing exercise should be encouraged; smoking and excessive alcohol should be avoided. Pharmacological treatment is recommended for men aged 50 or older who have had spine or hip fractures, those with T-scores of -2.5 or below, and men at high risk of fracture based on low bone mineral density and/or clinical risk factors. Treatment should be monitored with serial dual-energy x-ray absorptiometry testing.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Laboratory testing is indicated to exclude secondary causes of osteoporosis [1, 14, 17] (Table 4).”
From Clinician’s Guide to Prevention and Treatment of Osteoporosis (2014) · cites this paper as [17]
In the citing paper
“The Endocrine Society recommended that men with high fracture risk should receive an agent with proven antifracture activity irrespective of receiving testosterone or not (50).”
From A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management (2017) · cites this paper as [50]
Citations
Cites
Holick, M. F., Binkley, N. C., Bischoff-Ferrari, H. A., Gordon, C. M., Hanley, D. A., Heaney, R. P., Murad, M. H., & Weaver, C. M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0385 · Cited by 10,538
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Osteoporosis Prevention, Diagnosis, and Therapy
NIH Consensus Development Panel on Osteoporosis Prevention, D. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.6.785 · Cited by 5,529
An estimate of the worldwide prevalence and disability associated with osteoporotic fractures
Johnell, O., & Kanis, J. A. (2006) · Osteoporosis International · doi:10.1007/s00198-006-0172-4 · Cited by 4,704
Incidence and Economic Burden of Osteoporosis-Related Fractures in the United States, 2005–2025
Burge, R., Dawson-Hughes, B., Solomon, D. H., Wong, J. B., King, A., & Tosteson, A. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.061113 · Cited by 4,026
Ross, A. C., Manson, J. E., Abrams, S. A., Aloia, J. F., Brannon, P. M., Clinton, S. K., Durazo-Arvizu, R. A., Gallagher, J. C., Gallo, R. L., Jones, G., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2704 · Cited by 4,026
Black, D. M., Cummings, S. R., Karpf, D. B., Cauley, J. A., Thompson, D. E., Nevitt, M. C., Bauer, D. C., Genant, H. K., Haskell, W. L., Marcus, R., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)07088-2 · Cited by 3,846
Epidemiology of adult fractures: A review
Court-Brown, C. M., & Caesar, B. (2006) · Injury · doi:10.1016/j.injury.2006.04.130 · Cited by 3,672
Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis
Black, D. M., Delmas, P. D., Eastell, R., Reid, I. R., Boonen, S., Cauley, J. A., Cosman, F., Lakatos, P., Leung, P. C., Man, Z., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067312 · Cited by 2,986
Self-citationVitamin D deficiency: a worldwide problem with health consequences
Holick, M. F., & Chen, T. C. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.4.1080s · Cited by 2,689 · cited 2×
“Vitamin D at high doses may result in toxicity (hypercalcemia or hypercalciuria), but this is rarely seen unless 25(OH)D levels exceed 150 ng/ml (375 nmol/liter) (121), and such levels are unlikely with the doses of vitamin D recommended here.”
Background
Research works printed but not linked: 4
- Rao, 1996, Metabolic bone disease in gastrointestinal, hepatobiliary, and pancreatic disorders, 306
- Siegel, 1995, Metabolic bone diseases and disorders of the gastrointestinal tract, 113
- Barragry, 1978, Intestinal cholecalciferol absorption in the elderly and in young subjects., Clin Sci Mol Med, 55, 213
- Finkelstein, 2008, Toward a physiologically-based definition of hypogonadism in men: dose-response relationship between testosterone and bone resorption (Abstract 1102). ASBMR 30th Annual Meeting 1001–1300., J Bone Miner Res, 23, S2
Cited by
Items 601–669 of 669
Capito, J. E., Allison, R. L., Phillips, M. D., Xiang, J. Y., Rahman, A., Wanstreet, R., Brenwalt, A., Peckens, S., Maroon, M., Ashcraft, A. M., et al. (2025) · Journal of Primary Care & Community Health · doi:10.1177/21501319251400846
Efectos de la deprivación androgénica sobre el hueso
Varsavsky, M., & Alonso, G. (2014) · Elsevier eBooks · doi:10.1016/b978-84-9022-503-5.00013-7
Rojas, C. R. (2012) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Zhu, B., Hu, S., Guo, J., Dong, Z., Dong, Y. S., & Li, F. (2023) · Figshare · doi:10.6084/m9.figshare.23258773
Zhu, B., Hu, S., Guo, J., Dong, Z., Dong, Y. S., & Li, F. (2023) · Figshare · doi:10.6084/m9.figshare.23258770
Zhu, B., Hu, S., Guo, J., Dong, Z., Dong, Y. S., & Li, F. (2023) · Figshare · doi:10.6084/m9.figshare.23258761
Zhu, B., Hu, S., Guo, J., Dong, Z., Dong, Y. S., & Li, F. (2023) · Figshare · doi:10.6084/m9.figshare.23258767
Nichols, M. D. (2018) · OhioLink ETD Center (Ohio Library and Information Network)
Doeltreffendheid van voedingsinterventies verbeteren: een zoektocht naar nieuwe methodes
Verbeke, J. (2024) · Lirias (KU Leuven)
dos Santos, Z. A. (2014) · Repository of UTAD (Universidad De Tras-os Montes e Alto Douro)
Analiza lečenja osteoporoze u kliničkoj praksi metodom proučavanja sa tri različita aspekta
Ilić, D. (2016) · National Repository of Dissertations in Serbia
Kurzfassung der ESCP-Guidelines: Clinical Guidelines to Osteoporosis in Men
Bernecker, P. M. (2013) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Under (de)construction. The operationalization of gender in Parkinson’s research
Göttgens, I. L. E. (2024) · Radboud Repository (Radboud University)
Syddall, H. E. (2012) · ePrints Soton (University of Southampton)
ЧАСТОТА И СТРУКТУРА ОСНОВНЫХ ФАКТОРОВ РИСКА У ЖЕНЩИН C ПОСТМЕНОПАУЗНЫМ ОСТЕОПОРОЗОМ
И.В., П. (2018) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
Kheder, M., Vandepeer, M., Forel, D., & Tivey, D. (2021) · Repository of the Ludwig Boltzmann Institute of Health Technology Assessment (Ludwig Boltzmann Institute of Health Technology Assessment)
Benedetti, M., Celestini, M., Cisari, C., Fiore, P., Gimigliano, R., Iolascon, G., Panella, L., Pasquetti, P., Saraceni, V. M., Smania, N., et al. (2013) · Nova Science Publishers (Nova Science Publishers, Inc.)
Yu, C.-G., Shin, J.-W., Lee, B. H., Kim, H., Moon, S.-H., Park, S.-Y., & Kwon, J.-W. (2025) · Journal of Advanced Spine Surgery · doi:10.63858/jass.15.2.114
Pathogenetic and diagnostic features of osteoporosis in men
Холманских, А. С., & Lesnyak, O. M. (2025) · Russian Family Doctor · doi:10.17816/rfd697563
Kao, C., Meng, E., Cha, T., Wu, C.-T., Tsai, Y.-T., Tsao, C., & Yang, M.-H. (2026) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2026.111033
Management of male osteoporosis in primary care: clinical approach and pharmacotherapy
Poh, S. X. J., Choong, D. S., Gani, L. U., & Chua, A. L. A. (2026) · Singapore Medical Journal · doi:10.4103/singaporemedj.smj-2025-091
А cost-utility analysis of the surgical treatment of osteoporotic fractures in men
Димитров/Dimitrov, Н. /., & Гойчева/Goycheva, П. /. (2015) · Bulgarian Portal for Open Science
Prevence sekundárních fraktur: multioborové konsenzuální stanovisko ke klinickým doporučením
Conley, R. B., Adib, G., Adler, R. A., Kristina, K. E., Ivy, A. M., Amenta, K. C., Robert, B. D., Brox, W. T., Emily, C. E., Chapman‐Novakofski, K., et al. (2020) · Clinical Osteology · doi:10.36290/clo.2020.002
Self-citationMusculoskeletal and metabolic effects of androgen deprivation therapy in men with prostate cancer
Radev, S., Siderova, M. V., & Dimitrova, Y. (2026) · Scripta Scientifica Medica · doi:10.14748/sr9y5s28
A case of osteoporotic fracture leading to diagnosis of Klinefelter syndrome in a 76-year-old man
Shapiro, J., & Oprea, M. (2026) · JCEM Case Reports · doi:10.1210/jcemcr/luag035
Daho, Y. C., & Bencherif, M. D. (2021) · Dépôt Institutionnel de lUniversité de Tlemcen
Sanchez-Galvez, A., Serradilla-Gil, A. M., Illescas-Vacas, A., Lazo, A., Nuño-Rodriguez, M. C., Peña-Perea, M.-T., Linares-Mesa, N. A., Generoso, R. C., Cabezas, S. G., & Blanco-Villar, M. L. (2026) · Precision Oncology · doi:10.3390/precisoncol1010006
Bone Characteristics in Young Basketball Players and Middle-Aged Former Basketball Players
Chalouhi, G. A. (2023) · theses.fr (ABES) · doi:10.70675/2f4e24aezb5aez4633z9314z3853346b7d8f
Sehgal, C. L., Bhutani, K., & Sharma, A. (2026) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2026v19i4.58588
Recommendations for the diagnosis, prevention and treatment of osteoporosis in men
Grygorieva, N. V., Корж, М. О., Tronko, M. D., Mankovsky, B. M., Yatsyshyn, R. I., Golovach, I. Y., Страфун, С. С., Сміян, С. І., Gurzhenko, Y. M., Рекалов, Д. Г., et al. (2026) · TRAUMA · doi:10.22141/1608-1706.2.27.2026.1081
Relationship Between Serum Testosterone And Osteoporosis In Older Men: A Cross-Sectional Study
Alam, A. R., Mustari, M. N., Latief, J., Rasjad, C., Bausat, A., Zainuddin, A. A., Prihantono, P., & Faruk, M. (2026) · THE NEW ARMENIAN MEDICAL JOURNAL · doi:10.56936/18290825-2026.20v.1-67
Loures, M. A. A. D. R., Zerbini, C. A. F., de Azevedo, E., Martinez, L. C., Guimarães, M. F. B. D. R., Franco, A. S., Paupitz, J. A., Bezerra, M. C., Szejnfeld, V. L., Soares, M. R. M. P., et al. (2026) · Archives of Osteoporosis · doi:10.1007/s11657-026-01709-6
Bone Metabolism and Testicular Dysfunction
Graziani, A., Grande, G., & Ferlin, A. (2026) · Endocrinology · doi:10.1007/978-3-319-29456-8_51-1
Alhogbani, M., Bazarbashi, S. N., Alsharm, A. A., Rabah, D. M., Tashkandi, E. M., Alrabiah, K., Aseafan, M., Alhomsi, M., Ashour, M., Almansour, M., et al. (2026) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2026.101280
Management of Osteoporosis and Low Bone Mass in Kidney Disease
Mulroy, M. C., Primbas, A. D., Salusky, I. B., Weinreb, J. E., & Shieh, A. (2026) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.0000001149
Valenzuela‐Vallejo, L., Zhang, C., Liu, E. Y., Salifu, K., Samelson, E. J., Rosen, H. N., & Mukamal, K. J. (2026) · Bone · doi:10.1016/j.bone.2026.117944
Hatta, S., Eguchi, Y., TAMURA, T., Sakamoto, S., Miyako, S., Toyoguchi, T., Shin, H., Kobayashi, T., Abe, Y., Saito, S., et al. (2026) · Journal of Orthopaedic Science · doi:10.1016/j.jos.2026.06.015
Osteoporotic Fracture, Diagnostic Activity, and Treatment in Patients With Gout
Holladay, E. E., Zhang, J., Xie, F., Gaffo, A., Woods, A., Daigle, S. G., LaMoreaux, B. D., & Curtis, J. R. (2026) · Arthritis Care & Research · doi:10.1002/acr.80134
Huang, Y.-C., Kao, S.-Y., Chen, Y., & Cheng, M.-T. (2026) · Osteoporosis International · doi:10.1007/s00198-026-08192-2
Male osteoporosis: pathophysiology, risk assessment, and evidence-based management
Tekin, S., & Gürlek, A. (2026) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.55730/1300-0144.6337
Su, W., Xiao, S., Li, Y., & Yuan, Z. (2026) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2026.08.009
Kobayashi, V., Baluyut, G. T. C., & Baluyut, G. T. C. (2026) · medRxiv · doi:10.64898/2026.09.03.26362168
Krikelis, M. I., Divaris, E., Pappa, A., Kassi, E., Anagnostis, P. G., & Tournis, S. (2026) · Maturitas · doi:10.1016/j.maturitas.2026.109125
Regmi, A., Sami, A., Baral, S., Jain, V. K., & Iyengar, K. P. (2026) · The Knee · doi:10.1016/j.knee.2026.104637
OSTEOPOROZ ZAMANI MİNERAL MÜBADİLƏSİNİN KOMPONENTLƏRİ
Həsənova, H., & Əzizova, G. (2023) · Nature & Science · doi:10.36719/2707-1146/38/18-22
Treatment sequence and treatment goals following osteoporotic vertebral compression fractures
Beall, D. P., Webb, J. R., Beall, O. A., Johnson, J. C., Kaufmann, A., Beall, S. E., Elghzali, A., Rahimi, M., & Khan, S. A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33042-1.00004-1
Options for osteoporosis treatment
Beall, D. P., Webb, J. R., Beall, O. A., Chong, C. C. W., Johnson, J. C., Beall, S. E., Lanio, A. F., Kaufmann, A., El-Shawaf, M. W., Elghzali, A., et al. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33042-1.00008-9
Beall, D. P., Beall, O. A., Webb, J. R., Johnson, J. C., & Mahmoud, A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33042-1.00002-8
Key findings on the efficacy and safety of testosterone therapy from two large randomized trials
Braga, M., & Basaria, S. S. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag397
Gkastaris, K. (2023) · Acta Orthopaedica Et Traumatologica Hellenica
Motta, G. (n.d.) · Institutional Research Information System University of Turin (University of Turin)
Genetic epidemiology of longitudinal change in bone mineral density
Dios, K. D. (2025) · OPUS - Open Publications of UTS Scholars (University of Technology Sydney)
Efecto del ranelato de estroncio sobre la densidad mineral ósea en hombres con osteoporosis
Costanzo, P., Salerni, H., & SANCHEZ, A. (2024) · Actualizaciones en osteología
Sølling, A. S., Paccou, J., Anastasilakis, A. D., Reid, I. R., Yavropoulou, M. P., Hauser, B., Naciu, A. M., Morin, S. N., Cauley, J. A., Abrahamsen, B., et al. (2026) · Journal of Bone and Mineral Research · doi:10.1093/jbmr/zjag145
Rutter, M. M., Crane, J. L., Babalola, F., Benjamin, R. W., Lam, C., McAdam, L. C., Nicolau, S., Sbrocchi, A. M., Scavina, M. T., Sorbara, J., et al. (2026) · Journal of Neuromuscular Diseases · doi:10.1177/22143602261486896
Ávila, J. D. B., Toapanta, K. E. S., Santana, C., & Laura, G. G. I. (2026) · Impact Research Journal · doi:10.63380/irj.v4n2.2026.423
Quality of osteoporosis management guidelines produced in China: a systematic review
Liu, X., Ge, M., Wu, C., Shen, K., Yang, J., & Sun, S. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1907308
Osteoporosis Screening Gaps Among Patients Undergoing Lumbar Fusion Surgery
Mao, E., Ceballos-Alvarez, K. E., Thai, S., Wang, J., & Jain, A. B. (2026) · Journal of the American Academy of Orthopaedic Surgeons · doi:10.5435/jaaos-d-26-00335
Schumacher, M., & Ghoumari, A. M. (2026) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2026.101293
Musculoskeletal problems of people with hemophilia aged > 65 years
Rodriguez-Merchan, E. C., Ribbans, W. J., & la Corte‐Rodríguez, H. D. (2026) · World Journal of Orthopedics · doi:10.5312/wjo.126620
Lee, Y.-Y., Huang, Y.-C., Kao, S.-Y., Chen, Y.-C., & Cheng, M.-T. (2026) · Archives of Osteoporosis · doi:10.1007/s11657-026-01782-x
Screening for Osteoporosis in Men Over Fifty With No Fracture History
Jumah, M. A., Alharbi, R. M., Alsalhi, A. K., Almutairi, S. A., Algharbi, O. A., Tayeb, R. K., Alhulaili, H. A., Alharbi, K. S., Alnemer, N. S., Makki, A. M., et al. (2026) · Journal of Healthcare Sciences · doi:10.52533/johs.2026.60118
Lemoli, M., Delbarba, A., Ciuceis, C. D., Rossini, C., Mori, L., Cotelli, S., Buso, G., Stassaldi, D., Buoso, C., Rosei, E. A., et al. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1907515
CARNEIRO, F. S. M., Giachini, F. R. C., Fonseca, M. P., Porto, A. A., Santos, J. D., & Tostes, R. C. (2026) · Pharmacological Reviews · doi:10.1016/j.pharmr.2026.100173
Pacharne, S., Livesey, M., Kadmiel, M., Wang, N., Caron, K. M., Richards, G. O., & Skerry, T. M. (2022) · doi:10.3389/fendo.2021.807882.s001
Tenev, D., Cherkezov, N., Enev, G., Raykov, G., & Dimitrov, N. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15228962
Gong, Y., Wang, W., Liu, Q., Zhang, P., & Li, C. (2026) · International Journal of General Medicine · doi:10.2147/ijgm.s634048
Metadata
- Authors
- Watts, N. B., Adler, R. A., Bilezikian, J. P., Drake, M. T., Eastell, R., Orwoll, E. S., & Finkelstein, J. S.
- Affiliations
- Mercy Health (US)
- Virginia Commonwealth University (US)
- Columbia University (US)
- Mayo Clinic (US)
- University of Sheffield (GB)
- Oregon Health & Science University (US)
- Harvard University (US)
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2012-06-01
- Volume
- 97
- Issue
- 6
- Pages
- 1802-1822
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2075195284
- Cited by
- 611
- References
- 216
- Citations by year
- 2026: 38 · 2025: 42 · 2024: 32 · 2023: 46 · 2022: 53 · 2021: 41 · 2020: 49 · 2019: 36 · 2018: 48 · 2017: 39 · 2016: 42 · 2015: 31 · 2014: 50 · 2013: 51 · 2012: 11
- FWCI
- 48.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
- Health Sciences › Medicine › Oncology › Bone health and treatments
- Keywords
- male osteoporosis, osteoporosis management, fracture risk assessment, dual-energy X-ray absorptiometry, bone mineral density, calcium and vitamin D supplementation, weight-bearing exercise, smoking, alcohol consumption, T-score, osteopenia, older men
- MeSH terms
- Aged, Endocrinology, Humans, Male, Middle Aged, Osteoporosis, Risk Factors, Evidence-Based Medicine, Consensus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.